Cargando…
Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening
3 controlled cohorts of mass-screening for colorectal cancer using a biennial faecal occult blood (HemoccultII®) test on well-defined European populations have demonstrated a 14% to 18% reduction in specific mortality. We aimed to estimate the sensitivity (S) of this HemoccultII®test and and also me...
Autores principales: | Jouve, J L, Remontet, L, Dancourt, V, Lejeune, C, Benhamiche, A M, Faivre, J, Esteve, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363664/ https://www.ncbi.nlm.nih.gov/pubmed/11384097 http://dx.doi.org/10.1054/bjoc.2001.1752 |
Ejemplares similares
-
Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study
por: Faivre, J, et al.
Publicado: (1999) -
Detection of Gastrointestinal Pathogens from Stool Samples on Hemoccult Cards by Multiplex PCR
por: Alberer, Martin, et al.
Publicado: (2017) -
Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba
por: Decker, Kathleen M., et al.
Publicado: (2018) -
Colorectal cancer screening completion: An examination of differences by screening modality
por: Finney Rutten, Lila J., et al.
Publicado: (2020) -
Corrigendum to “Detection of Gastrointestinal Pathogens from Stool Samples on Hemoccult Cards by Multiplex PCR”
por: Alberer, Martin, et al.
Publicado: (2017)